Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+-Year Results From a Multicenter, Open-Label Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 28, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 28, 2026
Impact of tofacitinib on growth in patients with juvenile idiopathic arthritis.
Journal: Annals of the rheumatic diseases
Published: November 28, 2025
A Canadian Advanced Physiotherapist Practitioner Shared-Care Model in Pediatric Rheumatology Offers Safe and Quality Care in the Management of Juvenile Idiopathic Arthritis-Comparing Key Performance Indicators with the PR-COIN Registry.
Journal: Children (Basel, Switzerland)
Published: November 10, 2025
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis.
Journal: The Journal of rheumatology
Published: September 22, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
Journal: The Journal of rheumatology
Published: August 05, 2025
Editorial: Building a learning health system in pediatric rheumatology.
Journal: Frontiers in pediatrics
Published: February 25, 2025
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force.
Journal: Annals of the rheumatic diseases
Published: November 08, 2024
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 08, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
Journal: The Journal of rheumatology
Published: July 16, 2024
Achieving reliable patient reported outcomes collection to measure health care improvement in a learning health network: lessons from pediatric rheumatology care and outcomes improvement network.
Journal: Frontiers in pediatrics
Published: June 04, 2024
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network.
Journal: Frontiers in pediatrics
Published: May 17, 2024
Last Updated: 09/26/2026